Forte Biosciences, Inc.FBRXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank44
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P44
Within normal range
Average
-19746.92%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%+100.0%
2018-242.26%+99.7%
2017-89524.39%-40.7%
2016-63614.29%-44.3%
2015-44088.24%-